RBM10 decreases the activation of RAP1 and reduces the phosphorylation of CREB via the AKT signalling pathway, suggesting that RBM10 exhibits its effect on lung adenocarcinoma cell proliferation via the RAP1/AKT/CREB signalling pathway. Here, AKT1 is linked to lung adenocarcinoma.